Role of genetically engineered mesenchymal stem cell exosomes and LncRNAs in respiratory diseases treatment

• Published in: Pathology, research and practice research and practice, 2024-02, Vol.254, p.155135-155135, Article 155135
• Main Authors: Jasim, Saade Abdalkareem, Aziz, Dhifaf Zeki, Mustafa, Yasser Fakri, Margiana, Ria, Al-Alwany, Ameen Abdulhasan, Hjazi, Ahmed, Alawadi, Ahmed, Yumashev, Alexey, Alsalamy, Ali, Fenjan, Mohammed N.
• Format: Article
• Language: English
• Subjects: Cell-free therapies; Immunomodulation; Inflammation; Mesenchymal stem cell; Respiratory disease; Tissue regeneration
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2024.155135

The term acute respiratory disease encompasses a wide range of acute lung diseases, which in recent years have been ranked among the top three deadly diseases in the world. Since conventional treatment methods, including the use of anti-inflammatory drugs, have had no significant effect on the treatment process of these diseases, the attention of the medical community has been drawn to alternative methods. Mesenchymal stem cells (MSC) are multipotential stem/progenitor cells that have extensive immunomodulatory and anti-inflammatory properties and also play a critical role in the microenvironment of injured tissue. MSC secretomes (containing large extracellular vesicles, microvesicles, and exosomes) are a newly introduced option for cell-free therapies that can circumvent the hurdles of cell-based therapies while maintaining the therapeutic role of MSC themselves. The therapeutic capabilities of MSCs have been showed in many acute respiratory diseases, including chronic respiratory disease (CRD), novel coronavirus 2019 (COVID −19), and pneumonia. MSCs offer novel therapeutic approaches for chronic and acute lung diseases due to their anti-inflammatory and immunomodulatory properties. In this review, we summarize the current evidence on the efficacy and safety of MSC-derived products in preclinical models of lung diseases and highlight the biologically active compounds present in the MSC secretome and their mechanisms involved in anti-inflammatory activity and tissue regeneration.